The FDA plays a central role in the implementation of the BPCA. It is responsible for identifying the need for pediatric studies and issuing Written Requests to drug manufacturers. The FDA also reviews the submitted studies to ensure they meet the required standards for quality and relevance. Additionally, the FDA maintains a publicly accessible list of drugs for which pediatric studies are needed, helping to guide research priorities.
